BioCorRx Inc. financial data

Symbol
BICX on OTC
Location
2390 East Orangewood Avenue, Suite 570, Anaheim, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.22 % +75.9%
Quick Ratio 0.82 %
Debt-to-equity -143 % -35.8%
Return On Equity 6.91K % +8365%
Return On Assets -98.4 % +90.8%
Operating Margin -572 % +96.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.7M shares +117%
Common Stock, Shares, Outstanding 11.2M shares 0%
Entity Public Float 2.72M USD -70.5%
Common Stock, Value, Issued 20.2K USD +80.1%
Weighted Average Number of Shares Outstanding, Basic 17M shares +79.8%
Weighted Average Number of Shares Outstanding, Diluted 18.2M shares +66.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 948K USD +3465%
Cost of Revenue 0 USD -100%
Research and Development Expense 1.74M USD +29.7%
General and Administrative Expense 711K USD -27.6%
Operating Income (Loss) -5.42M USD -12.5%
Nonoperating Income (Expense) 1.16M USD +675%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.27M USD +13.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.26M USD -7.18%
Earnings Per Share, Diluted -0.11 USD/shares +21.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 194K USD
Inventory, Net 155K USD
Assets, Current 1.46M USD +314%
Property, Plant and Equipment, Net 7.69K USD -75.7%
Operating Lease, Right-of-Use Asset 169K USD -18.8%
Goodwill 2.84M USD
Assets 7.53M USD +1071%
Accounts Payable, Current 6.73M USD +117%
Liabilities, Current 15M USD +82.8%
Operating Lease, Liability, Noncurrent 128K USD -24.6%
Liabilities 20.3M USD +60.5%
Retained Earnings (Accumulated Deficit) -87.2M USD -6.29%
Stockholders' Equity Attributable to Parent -13.5M USD -14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -12.8M USD -6.34%
Liabilities and Equity 7.53M USD +1071%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -690K USD -103%
Net Cash Provided by (Used in) Financing Activities 626K USD +66.6%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 20.2M shares +80.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 288K USD +220%
Interest Paid, Excluding Capitalized Interest, Operating Activities 722 USD -91.6%
Deferred Tax Assets, Valuation Allowance 12.3M USD +9.97%
Deferred Tax Assets, Gross 12.4M USD +8.39%
Operating Lease, Liability 209K USD +197%
Depreciation 22.1K USD -14%
Lessee, Operating Lease, Liability, to be Paid 209K USD -16.4%
Property, Plant and Equipment, Gross 195K USD 0%
Operating Lease, Liability, Current 41.7K USD +6.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 27.3K USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.6K USD -65.3%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 54.5K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 8.25M USD +3.51%
Preferred Stock, Shares Issued 160K shares
Preferred Stock, Shares Authorized 600K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 54.5K USD 0%
Operating Lease, Payments 4.55K USD
Additional Paid in Capital 73.6M USD +4.99%
Preferred Stock, Shares Outstanding 160K shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 203K USD +64.1%
Interest Expense 282K USD -62.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares